drugset / Trial / NCT00962026
Rilonacept in Diabetes Mellitus Type 1: Safety Study
NaSingle-groupOpen-labelTreatment
Summary
This study is being done to see if an investigational drug called rilonacept is safe to use in patients with type 1 diabetes, and if it can slow the loss of the body's ability to secrete insulin in patients who are still able to make a small amount of insulin.
Timeline
- Start
- 2011-02
- Primary completion
- 2013-03
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rilonacept | Protein / enzyme biologic | — | Subcutaneous |